AdvisorShares Pure Cannabis ETF
YOLO
Market cap $41.3M

3.22 USD

+0.01

0.31%

At close Oct 4, 4:00 PM EDT

1 day

0.31%

5 days

-4.17%

1 month

0.94%

3 months

-2.42%

6 months

-22.22%

Year to date

5.92%

1 year

3.21%

5 years

-78.35%

0

Funds holding %

of 6,728 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

294% more call options, than puts

Call options by funds: $63K | Put options by funds: $16K

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

3% more funds holding

Funds holding: 58 [Q1] → 60 (+2) [Q2]

2.93% less ownership

Funds ownership: 10.94% [Q1] → 8.02% (-2.93%) [Q2]

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

39% less capital invested

Capital invested by funds: $5.73M [Q1] → $3.48M (-$2.26M) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for YOLO.

See Analyst Rankings

Financial journalist opinion

Proactive Investors

Cannabis stocks rally as Trump backs rescheduling, Florida legalization

Cannabis shares gained traction during Monday's session after Donald Trump endorsed the federal rescheduling of marijuana to allow research into its medical benefits. In a post on his social media platform Truth Social, the Republic presidential candidate said his administration would pass “common sense laws,” specifically the SAFER Banking Act and rescheduling cannabis to the lower-risk Schedule 3 of the Controlled Substances Act.

Cannabis stocks rally as Trump backs rescheduling, Florida legalization

Proactive Investors

Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election

Cannabis stocks moved lower on Tuesday as hopes that marijuana could be rescheduled as a lower-risk drug in the US before the upcoming election in November were dashed. Earlier this year, the Department of Justice (DOJ) in line with a recommendation from the Department of Health and Human Services proposed that because marijuana has accepted medical uses and less abuse potential than other substances in Schedules I and II of the Controlled Substances Act that the drug should be reclassified as Schedule III.

Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election

Proactive Investors

Cannabis stocks jump as Biden administration advances marijuana rescheduling proposal

US President Joe Biden confirmed on Thursday that the Justice Department is officially moving toward reclassifying cannabis as a lower-risk drug. The Justice Department's proposed rule will soon be posted which will be followed by a 60-day public comment period before the rule is potentially finalized, it was confirmed.

Cannabis stocks jump as Biden administration advances marijuana rescheduling proposal

ETF Prime: Rosenbluth on Spot Ether, Marijuana ETFs, and More

On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tickers, among other topics. Afterward, Bancreek CEO and CIO Andrew Skatoff spoke with Geraci about his investment philosophy.

ETF Prime: Rosenbluth on Spot Ether, Marijuana ETFs, and More

YTD Thematic Winners Reflect Change in Market Leadership

Looking at the ETFs with the highest returns YTD, a few thematic standouts have emerged. As a reminder regarding long-term investments, thematic investing is cyclical.

YTD Thematic Winners Reflect Change in Market Leadership

Investors wary of US cannabis ETFs despite recent rally

Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.

Investors wary of US cannabis ETFs despite recent rally

Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling

The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling

Marijuana reclassified federally in major win for the legal cannabis industry

The U.S. government will reclassify marijuana as less risky as the recreational marijuana business continues to grow.

Marijuana reclassified federally in major win for the legal cannabis industry

Biden Administration Moving Marijuana To Less Severe Drug Class—Boosting Medical Uses, Reports Say

The Drug Enforcement Administration is reportedly planning to reclassify marijuana so it is no longer categorized as one of the most dangerous and addictive drugs—a decision that would fall short of legalizing marijuana nationally, but could significantly lessen regulations on the drug while opening the door to more widespread medical use.

Biden Administration Moving Marijuana To Less Severe Drug Class—Boosting Medical Uses, Reports Say

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

See News Rankings

Charts implemented using Lightweight Charts™